Clinical trial
Improved Muscle Function in Duchenne Muscular Dystrophy Through L-Arginine and Metformin
NCT02516085 is registered in ClinicalTrials.gov with University Hospital, Basel, Switzerland as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Improved Muscle Function in Duchenne Muscular Dystrophy Through L-Arginine and Metformin
- Lead sponsor
- University Hospital, Basel, Switzerland
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- January 31, 2012
- Completion date
- October 31, 2012
- Enrollment
- 5 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
duchenne muscular dystrophy